Pressure Injury Prevention and Treatment

压力性损伤的预防和治疗

联系专家
  • white icon on blue background showing 59% prevelance rate

    来自90个国家1,117个ICU的13,254名患者的数据发现,ICU获得性压力性损伤的发生率为59%²

  • white icon on blue background showing a clock with six hours

    在持续负荷后6小时内会出现压力性损伤³

  • white icon on blue background showing 22.5% Hospital mortality rate

    ICU获得性压力损伤患者的住院死亡率为22.5%²

预防和治疗压力性损伤,您的最佳伙伴

  • Clinician applying Tagerderm to a pressure injury

    信息和推荐规范瞬息万变,很难跟上最新的指导方针。3M公司通过专业的培训和教育资源,帮助您的机构深化有关静脉输液护理最佳实践的专业知识,满足您的机构的独特挑战。


联系专家

非常感谢!

您的信息已提交成功! 如果您还想了解更多3M各个领域的解决方案,可以访问:www.3m.com/cn

最佳实践始于有效的解决方案

  • 2019年,国家压力性损伤顾问小组(NPIAP)、欧洲压力性溃疡顾问小组(EPUAP)和泛太平洋压力性损伤联盟(PPPIA)与近200名研究压力性损伤的学术和临床专家合作,发布了国际指南⁴,概述了评估和教育的推荐规范,以及预防和治疗方案,包括产品解决方案的理想特征。

    我们希望帮助您学习预防和治疗压力性损伤的推荐规范。3M公司基于以患者为中心的科学技术,拥有一系列多效治疗方案,其中包括皮肤保护、先进的伤口护理敷料和负压创伤治疗。

    此外,如您与3M公司合作,可获得相应的教学培训,以支持基于证据的标准,并为压力性损伤项目实施安全、高效和有效的解决方案。

    预防压力性损伤的治疗方案

    压力性损伤的管理方案

    教育和支持


预防性治疗方案:帮助您预防压力性损伤

在预防压力性损伤的指导方针中,包括制定预防性皮肤护理方案,以清洁皮肤、防止受潮,并使用预防性敷料保护骨性突起。⁴,


管理方案:帮助压力性损伤的患者痊愈

考虑使用负压创伤治疗(NPWT)作为早期的辅助治疗,减少3、4期压力性损伤的范围和程度。NPWT已被用作有效的一线伤口治疗方法。虽然最初并非针对治疗压力性损伤,但越来越多的证据支持NPWT用于压力性损伤治疗。⁴


使用多种先进的伤口敷料,帮助压力性损伤的愈合。

如已达到使用NPWT的标准,或者有替代的治疗方法,先进的伤口敷料可促进湿润的伤口愈合,更换敷料频率较低,使其成为一种具有成本效益的选择。⁴


gray banner image
您的教育和支持资源

针对您的设施,制定个性化的培训和教学,帮助您紧跟最新指导方针,增强团队的专业知识和技能。

查看3M资源
  • References:

    1. Health Research & Educational Trust (2016, January). Hospital Acquired Pressure Ulcers (HAPU) Change Package: 2016 Update. Chicago, IL: Health Research & Educational Trust. Accessed at www.hret-hen.org.
    2. Labeau SO, et al. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study. Intensive Care Med. 2020 Oct 9. doi: 10.1007/s00134-020-06234-9. Epub ahead of print. PMID: 33034686.
    3. Gefen A (2008) How much time does it take to get a pressure ulcer? Integrated evidence from human, animal, and in vitro studies. Ostomy Wound Manag 54:26–28, 30‑25
    4. European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Quick Reference Guide. Emily Haesler (Ed.).EPUAP/NPIAP/PPPIA:2019
    5. National Pressure Injury Advisory Panel. 2014 Guidelines. Prevention and Treatment of Pressure Ulcers: A Clinical Guide. Accessed at https://www.internationalguideline.com/static/pdfs/NPUAP-EPUAP-PPPIA-CPG-2017.pdf.
    6. Demarre L et al. (2015). Factors predicting the development of pressure ulcers in an at-risk population who receive standardized preventive care: secondary analyses of a multicentre randomised controlled trial. J Adv Nurs., 71(2):391-403.
    7. 3M data on file. LAB-05-385368.
    8. 3M data on file. EM-05-291517.
    9. Sieracki J, Wilkes R, Bennett E R, et al. (September 24, 2020) Finite Element Analysis Modeling of a Novel Silicone Dressing. Cureus 12(9): e10629. DOI 10.7759/cureus.10629
    10. Gabriel A, Camardo M, O’Rorke E, Gold R, Kim PJ. . Effects of Negative-Pressure Wound Therapy With Instillation versus Standard of Care in Multiple Wound Types. Plastic and Reconstructive Surgery. 2021;147(1S-1):68S–76S. doi: 10.1097/PRS.0000000000007614.
    11. Kharkar, P, PhD. Assessment of a Novel Drape Containing Acrylic and Silicone-based Adhesives When Using Negative Pressure Wound Therapy. Presented at SAWC Fall 2019, October 12-14, 2019, Las Vegas, NV 2019.
    12. Lemire JA, Kalan L, Gugala N, Bradu A, Turner RJ. Silver oxynitrate - an efficacious compound for the prevention and eradication of dual-species biofilms. Biofouling 2017;33(6):460-469. doi:10.1080/08927014.2017.132258
    13. Crawford Healthcare. Evaluation of KerraCel Ag and Aquacel Ag Extra to sequester bacteria. February 28, 2017. CHC R543.
    14. Cullen et al. A protease activity model to evaluate therapies in vitro. Poster presented at: European Wound Management Association (EWMA) 2012 Conference; May 23-25,2012; Vienna, AT.